2017-11-20 |
1 |
|
G. United States Patent Number 7,601,758 (“the ’758 Patent”), entitled
“METHODS FOR CONCOMITANT…States Patent Nos. 7,906,519; 7,935,731; 8,093,298; 7,964,648;
8,093,297; 7,619,004; 7,601,758; 7,820,681…722 Patents are collectively referred to herein as the “Gout Patents.” (The ’648 and ’297
patents are…are both FMF Patents and Gout Patents.)
27. All of the above-listed patents are collectively…648 Patent, including at least claim 1
of the ’648 patent, and that the claims of the ’648 Patent are |
External link to document |
2018-07-06 |
13 |
Patent/Trademark Report to Commissioner of Patents |
8,093,298; 7,964,648; 8,093,297; US 7,619,004; US 7,601,758; US 7,820,681; US 7,915,269; US 7,964,647; US … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731… 2017
6 July 2018
1:17-cv-01690
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2017-11-20 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298… 2017
6 July 2018
1:17-cv-01690
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |